JavaScript is disabled for your browser. Some features of this site may not work without it.
Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Advances in asthma management, particularly the introduction
of controller medication of which inhaled corticosteroids are
the most important, has resulted in a steady decline in asthma
mortality in most countries. This is usually accompanied
by a decline in episodes of near-fatal asthma attacks and
hospitalisations, and a reduction in other indicators of asthma
morbidity. These gains have led to a shift in thinking on
the management of asthma, away from simply preventing
death and hospitalisations, toward achieving and maintaining
sustained control of all clinical features.